Atavistik Bio, Inc.

Visit Website →
Funding: 2025 ($0.0M)

Oncology company reactivating tumor suppressors through novel metabolic targets. Based in New York, NY.

Open Positions (2)

Cambridge, MA Onsite Development
Cambridge, MA Onsite G&A